Mark J. Murray
Director/Board Member at Genevant Sciences Corp.
Profile
Mark J.
Murray was the founder of Protiva Biotherapeutics, Inc. founded in 2000, where he held the title of President & Chief Executive Officer from 2000 to 2008.
Currently, he is a Director at Genevant Sciences Corp.
Dr. Murray's former position was at Arbutus Biopharma Corp.
where he held the title of President, Chief Executive Officer & Director from 2011 to 2019.
Dr. Murray received a doctorate degree from Oregon Health & Science University.
Mark J. Murray active positions
| Companies | Position | Start |
|---|---|---|
Genevant Sciences Corp.
 Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Director/Board Member | - |
Former positions of Mark J. Murray
| Companies | Position | End |
|---|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Chief Executive Officer | 2019-06-23 |
Protiva Biotherapeutics, Inc.
 Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | Chief Executive Officer | 2008-12-01 |
Training of Mark J. Murray
| Oregon Health & Science University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Health Technology |
| Private companies | 2 |
|---|---|
Protiva Biotherapeutics, Inc.
Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | Health Technology |
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Health Technology |
- Stock Market
- Insiders
- Mark J. Murray
